Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Missouri › St. Louis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in St. Louis, MO
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 2
- Washington University Saint Louis, St Louis
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
RecruitingPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at West County Hospital, Creve Coeur · 12 mi away
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Washington University (Data Collection Only), St Louis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in other cities
- Houston, TX8 studies
- New York City, NY6 studies
- Columbus, OH5 studies
- Philadelphia, PA4 studies
- Washington, DC4 studies
- Seattle, WA3 studies
- Boston, MA3 studies
- Edison, NJ3 studies
- East Norwalk, CT3 studies
- Queens, NY3 studies
- Staten Island, NY3 studies
- New Rochelle, NY3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer65 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer36 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.